Hahn Mark W
SEC insider (Form 3/4/5 filer). CIK 0001408502. Director at SOLENO THERAPEUTICS INC (SLNO) and 1 other issuer. 46 reported Form 4/5 transactions since Sep 2024; latest on May 18, 2026. Located in LONDON, X0.
Companies Hahn Mark W has filed insider reports for
- SOLENO THERAPEUTICS INC (SLNO): Director
- Verona Pharma plc (VRNA): Officer, Chief Financial Officer
Hahn Mark W
CIK: 0001408502
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (46 total)
- May 18, 2026SLNO
SOLENO THERAPEUTICS INC
DispositionDirect10K shares- - Oct 13, 2025SLNO
SOLENO THERAPEUTICS INC
AwardDirect10K shares- - Oct 7, 2025VRNA
Verona Pharma plc
AwardDirectRestricted Share Unit
1.6M shares- - Oct 7, 2025VRNA
Verona Pharma plc
ExerciseDirect3.3M shares- - Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect3.3M shares- - Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect11.3M shares- - Aug 29, 2025VRNA
Verona Pharma plc
GiftDirect1.2M shares- - Aug 1, 2025VRNA
Verona Pharma plc
SaleDirect208.9K shares at avg. $13.14$2.7M - Aug 1, 2025VRNA
Verona Pharma plc
ExerciseDirect255.7K shares- - Jul 8, 2025VRNA
Verona Pharma plc
Tax PaymentDirect90.3K shares at avg. $11.44$1.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 18, 2026 |  SLNO SOLENO THERAPEUTICS INC | Disposition | 10,046 | - | $0 | Direct |
| Oct 13, 2025 | SLNO SOLENO THERAPEUTICS INC | Award | 10,046 | - | - | Direct |
| Oct 7, 2025 |  VRNA Verona Pharma plc | Award Restricted Share Unit | 1,649,952 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Exercise | 3,285,280 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 3,285,280 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 11,264,968 | - | - | Direct |
| Aug 29, 2025 | VRNA Verona Pharma plc | Gift | 1,200,000 | - | - | Direct |
| Aug 1, 2025 | VRNA Verona Pharma plc | Sale | 208,912 | $13.14 | $2,745,877 | Direct |
| Aug 1, 2025 | VRNA Verona Pharma plc | Exercise | 255,696 | - | - | Direct |
| Jul 8, 2025 | VRNA Verona Pharma plc | Tax Payment | 90,320 | $11.44 | $1,033,378 | Direct |
1-10 of 46 transactions